149 related articles for article (PubMed ID: 35153749)
1. Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer.
Yang J; Wu Z; Yang L; Jeong JH; Zhu Y; Lu J; Wang B; Wang N; Wang Y; Shen K; Li R
Front Pharmacol; 2021; 12():785981. PubMed ID: 35153749
[TBL] [Abstract][Full Text] [Related]
2. KIF2C promotes the proliferation of hepatocellular carcinoma cells
Gao Z; Jia H; Yu F; Guo H; Li B
Exp Ther Med; 2021 Oct; 22(4):1094. PubMed ID: 34504548
[TBL] [Abstract][Full Text] [Related]
3. KIF2C Facilitates Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma.
Huang X; Zhao F; Wu Q; Wang Z; Ren H; Zhang Q; Wang Z; Xu J
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900292
[TBL] [Abstract][Full Text] [Related]
4. Kinesin family member 2C promotes hepatocellular carcinoma growth and metastasis via activating MEK/ERK pathway.
Ding Q; Jiang C; Zhou Y; Duan J; Lai J; Jiang M; Lin D
Biosci Biotechnol Biochem; 2021 Oct; 85(11):2241-2249. PubMed ID: 34494081
[TBL] [Abstract][Full Text] [Related]
5. KIF2C Is a Novel Prognostic Biomarker and Correlated with Immune Infiltration in Endometrial Cancer.
An L; Zhang J; Feng D; Zhao Y; Ouyang W; Shi R; Zhou X; Yu Z; Wei S; Min J; Wang H
Stem Cells Int; 2021; 2021():1434856. PubMed ID: 34650608
[TBL] [Abstract][Full Text] [Related]
6. Down regulated oncogene
Mo S; Fang D; Zhao S; Thai Hoa PT; Zhou C; Liang T; He Y; Yu T; Chen Y; Qin W; Han Q; Su H; Zhu G; Luo X; Peng T; Han C
Ann Transl Med; 2022 Feb; 10(3):151. PubMed ID: 35284538
[TBL] [Abstract][Full Text] [Related]
7. Kinesin family member 2C aggravates the progression of hepatocellular carcinoma and interacts with competing endogenous RNA.
Zhang GP; Shen SL; Yu Y; Yue X; Hu WJ; Li SQ
J Cell Biochem; 2020 Nov; 121(11):4419-4430. PubMed ID: 32056305
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of kinesin family member 2C restricts cell proliferation and induces cell cycle arrest in gastric cancer.
Li S; Ma Y; Wu C; Hou X
Histol Histopathol; 2023 Aug; 38(8):907-916. PubMed ID: 36448588
[TBL] [Abstract][Full Text] [Related]
9. KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR-325-3p.
Gan H; Lin L; Hu N; Yang Y; Gao Y; Pei Y; Chen K; Sun B
Cell Biochem Funct; 2019 Aug; 37(6):424-431. PubMed ID: 31328811
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analysis of kinesin family member 2C in human tumors: novel prognostic biomarker and tumor microenvironment regulator.
Zhang B; Liu P; Li Y; Hu Q; Li H; Pang X; Wu H
Am J Cancer Res; 2022; 12(11):4954-4976. PubMed ID: 36504885
[TBL] [Abstract][Full Text] [Related]
11. Large-Scale Transcriptome Data Analysis Identifies KIF2C as a Potential Therapeutic Target Associated With Immune Infiltration in Prostate Cancer.
Zhang P; Gao H; Ye C; Yan R; Yu L; Xia C; Yang D
Front Immunol; 2022; 13():905259. PubMed ID: 35720323
[TBL] [Abstract][Full Text] [Related]
12. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis.
Shimo A; Tanikawa C; Nishidate T; Lin ML; Matsuda K; Park JH; Ueki T; Ohta T; Hirata K; Fukuda M; Nakamura Y; Katagiri T
Cancer Sci; 2008 Jan; 99(1):62-70. PubMed ID: 17944972
[TBL] [Abstract][Full Text] [Related]
13. KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker.
Kreis NN; Moon HH; Wordeman L; Louwen F; Solbach C; Yuan J; Ritter A
Crit Rev Clin Lab Sci; 2024 Feb; ():1-31. PubMed ID: 38344808
[TBL] [Abstract][Full Text] [Related]
14. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
[TBL] [Abstract][Full Text] [Related]
15. KIF2C is a Biomarker Correlated With Prognosis and Immunosuppressive Microenvironment in Human Tumors.
Zhang X; Li Y; Hu P; Xu L; Qiu H
Front Genet; 2022; 13():891408. PubMed ID: 35685442
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of the effects of KIF2C on prognosis, biological functions and immune infiltration in PAAD.
Xiong J; Wu R; He A; Hou P; Wang J; Zhang R; Liao W; Wu L; Li E
Tissue Cell; 2022 Oct; 78():101900. PubMed ID: 36029726
[TBL] [Abstract][Full Text] [Related]
17. KIF2C: An important factor involved in signaling pathways, immune infiltration, and DNA damage repair in tumorigenesis.
Li RQ; Yang Y; Qiao L; Yang L; Shen DD; Zhao XJ
Biomed Pharmacother; 2024 Feb; 171():116173. PubMed ID: 38237349
[TBL] [Abstract][Full Text] [Related]
18. MEF2C contributes to axonal branching by regulating Kif2c transcription.
Wu R; Sun Y; Zhou Z; Dong Z; Liu Y; Liu M; Gao H
Eur J Neurosci; 2024 Jun; 59(12):3389-3402. PubMed ID: 38663879
[TBL] [Abstract][Full Text] [Related]
19. Kinesin Kif2C in regulation of DNA double strand break dynamics and repair.
Zhu S; Paydar M; Wang F; Li Y; Wang L; Barrette B; Bessho T; Kwok BH; Peng A
Elife; 2020 Jan; 9():. PubMed ID: 31951198
[TBL] [Abstract][Full Text] [Related]
20. Kinesin family member 2C (KIF2C/MCAK) is a novel marker for prognosis in human gliomas.
Bie L; Zhao G; Wang YP; Zhang B
Clin Neurol Neurosurg; 2012 May; 114(4):356-60. PubMed ID: 22130050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
